Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents Tipranks - Fri Oct 10, 10:24AM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Lexaria Bioscience...

LEXX : 1.1200 (+0.90%)
Fed Meeting, U.S. Jobs in Focus for This Week Baystreet - Mon Jul 7, 8:15AM CDT

Tuesday U.S. Economic Lookahead NFIB optimism index (June) Consumer credit (May) ...

AZZ : 106.78 (+0.91%)
SAR : 22.76 (+1.43%)
CAG : 16.95 (-1.22%)
MTY.TO : 37.69 (+0.13%)
UNTY : 52.15 (-0.10%)
LEXX : 1.1200 (+0.90%)
PENG : 21.68 (+0.93%)
DAL : 67.24 (-0.37%)
BSET : 15.61 (+0.13%)
LEVI : 22.19 (-1.11%)
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock ACCESS Newswire - Mon Apr 28, 11:15AM CDT

KELOWNA, BC / ACCESS Newswire / April 28, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the closing...

LEXXW : 0.0252 (-0.79%)
LEXX : 1.1200 (+0.90%)
Lexaria Announces $2 Million Registered Direct Offering of Common Stock ACCESS Newswire - Fri Apr 25, 3:00AM CDT

KELOWNA, BC / ACCESS Newswire / April 25, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it...

LEXXW : 0.0252 (-0.79%)
LEXX : 1.1200 (+0.90%)
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology ACCESS Newswire - Wed Apr 23, 4:10AM CDT

Pfizer and Eli Lilly reporting significant - and opposing - news in the GLP-1 industry

LEXXW : 0.0252 (-0.79%)
LEXX : 1.1200 (+0.90%)
Lexaria Updates its Ongoing Human Study GLP-1-H24-4 ACCESS Newswire - Thu Apr 3, 4:10AM CDT

Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss

LEXXW : 0.0252 (-0.79%)
LEXX : 1.1200 (+0.90%)
Lexaria's Human GLP-1 Study #5 Begins Dosing ACCESS Newswire - Wed Apr 2, 4:05AM CDT

Head-to-head human study comparing traditional injected liraglutide to first-ever oral DehydraTECH-liraglutide

LEXXW : 0.0252 (-0.79%)
LEXX : 1.1200 (+0.90%)
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R) ACCESS Newswire - Tue Mar 18, 4:15AM CDT

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®

LEXXW : 0.0252 (-0.79%)
LEXX : 1.1200 (+0.90%)
The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience ACCESS Newswire - Thu Feb 27, 2:00AM CST

Lexaria executing a triple-pronged strategy in obesity and diabetes

LEXXW : 0.0252 (-0.79%)
LEXX : 1.1200 (+0.90%)
Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm ACCESS Newswire - Mon Feb 24, 2:00AM CST

5th study arm in 12-week Phase 1b Study receives lead clinical site approval

LEXXW : 0.0252 (-0.79%)
LEXX : 1.1200 (+0.90%)

Barchart Exclusives

Michael Burry Doubles Down on Molina Healthcare Stock. What Is the Bull Case for MOH Here? Barchart - 6 minutes ago
Burry finds value in holding this healthcare counter for the long term. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot